miR-21 Overexpression Promotes Esophageal Squamous Cell Carcinoma Invasion and Migration by Repressing Tropomyosin 1
Open Access
- 28 October 2020
- journal article
- research article
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2020, 1-10
Abstract
The migration and invasion of esophageal squamous cell carcinoma are associated with clinical outcomes, however, the mechanisms remain poorly understood. Here, we found that miR-21 is significantly overexpressed in ESCC, lung cancer, and bladder cancer compared with the adjacent normal tissue. MiR-21 and TPM1 expressions were analyzed by RT-qPCR and WB in 30 ESCC, 10 lung cancer, and 10 bladder cancer clinical specimens, each with matched adjacent normal tissue. Knockdown and overexpression of miR-21 as well as knockdown of TPM1 in ESCC cell lines were performed using synthetic oligonucleotides. TPM1 3UTR luciferase reporter constructs were used to investigate targeting of TPM1 by miR-21. ESCC migration and invasion were assessed using transwell migration and invasion assays. Inhibition of miR-21 reduced migration and invasion in two ESCC cell lines, and overexpression of miR-21 promoted migration and invasion in vitro. Interestingly, TPM1 exhibited inverse patterns of expression compared with miR-21 in tissues and cell lines. Luciferase reporter assays demonstrated that TPM1 was directly regulated by miR-21. Moreover, the forced overexpression of miR-21 repressed the TPM1 expression, while silencing of miR-21 restored the TPM1 expression in ESCC cell lines. What is more, simultaneous silencing of miR-21 and TPM1 expressions did not alter the migratory and invasive characteristics demonstrating that the effects of miR-21 were mediated through TPM1. In conclusion, the aberrant overexpression of miR-21 is common in cancer and promotes the migration and invasion of ESCC through inhibiting the TPM1 expression. These results suggest that miR-21 may be a novel predictive marker and therapeutic target for treatment of ESCC.Keywords
Funding Information
- Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun-Yat-Sen University (KLB09001, [2013]163, A2019543, 2019A1515010880, 2020A1515011378, 2019A1515011459)
- Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology (KLB09001, [2013]163, A2019543, 2019A1515010880, 2020A1515011378, 2019A1515011459)
- Guangdong Province Medical Research Fund (KLB09001, [2013]163, A2019543, 2019A1515010880, 2020A1515011378, 2019A1515011459)
- Natural Science Foundation of Guangdong Province (KLB09001, [2013]163, A2019543, 2019A1515010880, 2020A1515011378, 2019A1515011459)
This publication has 27 references indexed in Scilit:
- Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell CarcinomaPLOS ONE, 2013
- Multi-Modality Therapy for Cancer of the Esophagus and GE JunctionCurrent Treatment Options in Oncology, 2012
- Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinomaDiseases of the Esophagus, 2011
- MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell CarcinomaClinical Cancer Research, 2009
- Over- and under-expressed microRNAs in human colorectal cancerInternational Journal of Oncology, 2009
- Role of high‐molecular weight tropomyosins in TGF‐β‐mediated control of cell motilityInternational Journal of Cancer, 2007
- MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)Journal of Biological Chemistry, 2007
- microPrimer: the biogenesis and function of microRNADevelopment, 2005
- Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.Proceedings of the National Academy of Sciences, 1993
- Frequent mutation of the p53 gene in human esophageal cancer.Proceedings of the National Academy of Sciences, 1990